News of Note—Meissa’s chairman from J&J, Takeda and more

non
In this week's news of note, Meissa named a former Johnson & Johnson executive as chairman. (Pixabay)

Here's some other vaccine news of note for the week.

> Meissa Vaccines named Lawrence Blatt, Ph.D., Johnson & Johnson’s recent global head of infectious diseases and vaccines, as its chairman. Release

Takeda established a Center of Excellence in Singapore for vaccine development. It will hire and train local talent to work on the company's current and future vaccine candidates. Asian Scientist article

> An American expert told the Philippine Senate that he warned Sanofi on the health risks of Dengvaxia in 2016. The Manila Times article

PharmaJet is close to completing a $5 million financing round to fund the production of 5 million syringes to deliver the polio vaccine. MedCity News article

Valneva started a phase 1 study on its live-attenuated, single-dose vaccine candidate against Chikungunya. Release

> Researchers from Cardiff University have created the world’s first synthetic flu vaccine, which is given orally and is stable at room temperature. Cardiff University article